Royal Jelly

Royal Jelly

When worker bees decide to make a new queen, usually because the old one is either weakening or dead, they choose several small larvae and feed them with copious amounts of royal jelly in specially constructed queen cells. This type of feeding triggers the development of queen morphology, including the fully developed ovaries needed to lay eggs.
Royal jelly is widely marketed as a dietary supplement. It is an alternative medicine that falls under the category of apitherapy. Both the European Food Safety Authority and United States Food and Drug Administration have concluded that the current evidence does not support the claim of health benefits, and have actively discouraged the sale and consumption of the jelly. In the United States, the Food and Drug Administration has taken legal action against companies that have used unfounded claims of health benefits to market royal jelly products. There have also been documented cases of allergic reactions, namely hives, asthma, and anaphylaxis, due to consumption of royal jelly.



Main article: Major royal jelly protein
Major royal jelly proteins (MRJPs) are a family of proteins secreted by honey bees. The family consists of nine proteins, of which MRJP1 (also called royalactin), MRJP2, MRJP3, MRJP4, and MRJP5 are present in the royal jelly secreted by worker bees. MRJP1 is the most abundant, and largest in size. The five proteins constitute 83–90% of the total proteins in royal jelly. Royal jelly has been used in traditional medicine since ancient times, and the MRJPs are shown to be the main medicinal components. They are synthesised by a family of nine genes (mrjp genes), which are in turn members of the yellowfamily of genes such as in the fruitfly (Drosophila) and bacteria. They are attributed to be involved in differential development of queen larva and worker larvae, thus establishing division of labour in the bee colony.
Epigenetic effects
The honey bee queens and workers represent one of the most striking examples of environmentally controlled phenotypic polymorphism. Even if two larvae had identical DNA, one raised to be a worker, the other a queen, the two adults would be strongly differentiated across a wide range of characteristics including anatomical and physiological differences, longevity, and reproductive capacity. Queens constitute the female sexual caste and have large active ovaries, whereas female workers have only rudimentary, inactive ovaries and are functionally sterile. The queen/worker developmental divide is controlled epigenetically by differential feeding with royal jelly; this appears to be due specifically to the protein royalactin. A female larva destined to become a queen is fed large quantities of royal jelly; this triggers a cascade of molecular events resulting in development of a queen. It has been shown that this phenomenon is mediated by an epigenetic modification of DNA known as CpG methylation. Silencing the expression of an enzyme that methylates DNA in newly hatched larvae led to a royal jelly-like effect on the larval developmental trajectory; the majority of individuals with reduced DNA methylation levels emerged as queens with fully developed ovaries. This finding suggests that DNA methylation in honey bees allows the expression of epigenetic information to be differentially altered by nutritional input.
Use by humans
Adverse effects
Royal jelly may cause allergic reactions in humans ranging from hives, asthma, to even fatal anaphylaxis.The incidence of allergic side effects in people who consume royal jelly is unknown. The risk of having an allergy to royal jelly is higher in people who have other allergies.

Leave a comment

Related Posts

Enter your keyword